|
CTSO Cytosorbents Corp 1175151 |
| Balance Sheet |
|
Current Assets
|
$15,737,000.00 |
|
Assets
|
$37,960,000.00 |
|
Current Liabilities
|
$24,023,000.00 |
|
Liabilities
|
$38,711,000.00 |
|
Equity
|
$-751,000.00 |
|
Shares Out
|
62842748.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,745,000.00 |
|
Investing Cash Flow
|
$-39,000.00 |
| Market Analysis |
Market Cap
|
$19,481,251.88 |
|
Price
|
$0.31 |
|
BVPS
|
0.04 |
|
PB
|
7.75 |
|
EPS
|
-0.07 |
|
PS
|
0.55 |
|
FCF
|
$-1,770,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:57 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:47 |
| Apr |
May |
Jun |
| 2026-03-25 |
-0.07 |
|
|
2026-05-13 |
-0.05 |
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.05 |
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.04 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CTSO documents filed with the SEC.
CTSO Filings
Clear